U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment - Times of India

Home > Health
By FawasAb in Health
Updated 4 years ago

The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding

us-signs-agreement-with-astrazeneca-to-develop-supply-covid19-antibody-treatment-times-of-india